Robustness of safety signals generated by disproportionality analyses from spontaneous reporting systems: A meta-research study

被引：0
|
作者：
Fusaroli, M. [1 ]
Salvo, F. [2 ]
Bernardeau, C. [3 ]
Idris, M.
Dolladille, C. [4 ]
Pariente, A. [2 ]
Poluzzi, E. [5 ]
Raschi, E. [5 ]
Khouri, C. [3 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy
[2] CHU Bordeaux, Serv Pharmacol Med, Bordeaux, France
[3] Grenoble Alpes Univ Hosp, Pharmacovigilance Unit, Grenoble, France
[4] CHU Caen, Dept Pharmacol, Caen, France
[5] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2-014
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [41] Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study
    Bernardeau, Claire
    Revol, Bruno
    Salvo, Francesco
    Fusaroli, Michele
    Raschi, Emanuel
    Cracowski, Jean-Luc
    Roustit, Matthieu
    Khouri, Charles
    DRUG SAFETY, 2025,
  • [42] A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions
    Ying Li
    Patrick B. Ryan
    Ying Wei
    Carol Friedman
    Drug Safety, 2015, 38 : 895 - 908
  • [43] Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group
    Gould, A. Lawrence
    Lystig, Theodore C.
    Lu, Yun
    Fu, Haoda
    Ma, Haijun
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (01) : 65 - 75
  • [44] Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting Databases: A Report of the DIA Bayesian Safety Signal Detection Working Group
    A. Lawrence Gould
    Theodore C. Lystig
    Yun Lu
    Haoda Fu
    Haijun Ma
    Therapeutic Innovation & Regulatory Science, 2015, 49 : 65 - 75
  • [45] Comment on 'The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project'
    Braillon, Alain
    DRUG SAFETY, 2016, 39 (04) : 365 - 365
  • [46] Comment on ‘The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project’
    Alain Braillon
    Drug Safety, 2016, 39 : 365 - 365
  • [47] A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions
    Li, Ying
    Ryan, Patrick B.
    Wei, Ying
    Friedman, Carol
    DRUG SAFETY, 2015, 38 (10) : 895 - 908
  • [48] SAFETY OF PDE-5 INHIBITORS FOR ERECTILE DYSFUNCTION: DESCRIPTIVE AND DISPROPORTIONALITY ANALYSES OF THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE FROM 2010 TO 2022
    Shin, Y. E.
    Rojanasarot, S.
    Hincapie, A. L.
    Guo, J. J.
    VALUE IN HEALTH, 2023, 26 (06) : S189 - S190
  • [49] Checklist for Artificial Intelligence in Medical Imaging Reporting Adherence in Peer-Reviewed and Preprint Manuscripts With the Highest Altmetric Attention Scores: A Meta-Research Study
    Sivanesan, Umaseh
    Wu, Kay
    McInnes, Matthew D. F.
    Dhindsa, Kiret
    Salehi, Fateme
    van der Pol, Christian B.
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2023, 74 (02): : 334 - 342
  • [50] Drug Safety Signals Detected Using Electronic Health Records and Spontaneous Reporting Systems Data: The Experience of EU-ADR Project
    Patadia, Vaishali
    Schuemie, Martijn
    Coloma, Preciosa
    Gini, Rosa
    Herings, Ron
    Mazzaglia, Giampiero
    Picelli, Gino
    Fornari, Carla
    Pedersen, Lars
    van der Lei, Johan
    Sturkenboom, Miriam
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 342 - 343
12345